ArticleEuropean journal of dentistry2026
The Combination of Graphene and Polycaprolactone Scaffolds Enhancing Bone Mineralization and Hydroxyapatite.
Article in European journal of dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advanced Antibacterial Nanocomposite Fibers for Biomedical Applications.Pharmaceutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Objective: This study aimed to evaluate the effects of incorporating varying concentrations of graphene (0.5, 1.5, and 2.5 wt%) into polycaprolactone (PCL) scaffolds on mineralization and hydroxyapatite formation for bone tissue engineering applications. Materials and Methods: PCL scaffolds were fabricated with three different graphene concentrations: 0.5, 1.5, and 2.5 wt%. The scaffolds underwent characterization using Fourier-transform infrared spectroscopy (FTIR) to assess chemical composition and mineralization. Radiological imaging was employed to evaluate structural integrity and mineral density over a 21-day period. Additionally, histology analysis was performed to assess cellular interactions and scaffold integration. Results: FTIR analysis on day 7 indicated early mineralization across all scaffolds, evidenced by phosphate (∼1030 cm Conclusion: Incorporating graphene into PCL scaffolds enhances mineralization and hydroxyapatite formation, with the 2.5 wt% concentration achieving the most substantial effects. The 2.5 wt% graphene scaffold presents a balanced alternative, promoting steady mineralization and maintaining structural integrity, making it a promising candidate for bone tissue engineering applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.